- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00854178
Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery
January 5, 2010 updated by: UPECLIN HC FM Botucatu Unesp
The purpose of this study is to evaluate if the anesthetics propofol and isoflurane can damage DNA, induce apoptosis, change expression of genes related to apoptosis and DNA repair and change cytokines profile in patients submitted to elective surgery.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
It is expected that the results provide relevant information to understand the possible adverse effects of anesthetics and contribute to the establishment of strategies aimed at reducing the risks to exposed individuals.
Study Type
Interventional
Enrollment (Anticipated)
26
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Botucatu, São Paulo, Brazil, 18618-000
- Botucatu Medical School, UNESP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients in good health American Society of Anesthesia status physical I
- elective minor surgery
- general anesthesia
Exclusion Criteria:
- smokers
- alcoholics
- previous medication or radiation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 2
|
Isoflurane 1,0 minimum alveolar concentration Propofol 2mg/kg and 4ug/ml
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluation of genotoxicity, gene expression, apoptosis and cytokines profile
Time Frame: within 1 day after surgery
|
within 1 day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mariana G Braz, MsC, Department of Pathology, Botucatu Medical School, São Paulo State University, UNESP
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2008
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
March 2, 2009
First Submitted That Met QC Criteria
March 2, 2009
First Posted (Estimate)
March 3, 2009
Study Record Updates
Last Update Posted (Estimate)
January 6, 2010
Last Update Submitted That Met QC Criteria
January 5, 2010
Last Verified
January 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- upeclin/HC/FMB-Unesp-20
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on DNA Damage
-
Bispebjerg HospitalSygehus LillebaeltActive, not recruitingDNA Damage | Ultraviolet Rays; Injury | DNA Adduct Formation | DNA Damage, Radiation InducedDenmark
-
University of ZagrebUniversity of Split, School of MedicineRecruiting
-
University of Split, School of MedicineRecruiting
-
Tahitian Noni International, Inc.University of Illinois at ChicagoCompletedDNA DamageUnited States
-
Tufts UniversityBASFCompleted
-
Muğla Sıtkı Koçman UniversityCompleted
-
Zeynep Kamil Maternity and Pediatric Research and...Not yet recruitingDNA Damage | Granulosa Cells
-
Ricard MarcosFinnish Institute of Occupational HealthRecruitingOccupational Exposure | Genotoxicity | Damage DnaFinland, Spain
-
University of South FloridaCompletedDNA Damage | Other Complications Associated With Artificial FertilizationUnited States
-
McMaster UniversityNot yet recruitingOxidative Stress | Radiation Exposure | DNA Damage, Radiation Induced
Clinical Trials on Comparison of two anesthetic drugs
-
University of Alabama at BirminghamTerminatedMycoplasma Genitalium InfectionUnited States
-
Multan Medical And Dental CollegeCompleted
-
Jordan Collaborating Cardiology GroupCompletedVasovagal Syncope | Smoke InhalationJordan
-
University Hospital, MotolCompletedCoagulation Defect; Bleeding
-
University of MalayaUnknownEndotracheal Intubation in Bed up Head Elevation Position in Rapid Sequence InductionMalaysia
-
Centre Hospitalier Universitaire de BesanconTerminated
-
The Netherlands Cancer InstituteErasmus Medical Center; Amsterdam University Medical Centres (AUMC)Active, not recruitingCRC | Advanced NeoplasiaNetherlands
-
King's College Hospital NHS TrustHemabRecruiting
-
Izmir Dr Suat Seren Chest Diseases and Surgery...Completed
-
Katalin KissGöteborg UniversityRecruitingAcute Kidney Injury | Chronic Kidney InsufficiencySweden